Nephropathic Cystinosis Treatment - Global Market Outlook (2019-2027)

   |      |      |  

Nephropathic Cystinosis Treatment - Global Market Outlook (2019-2027)

"The Global Nephropathic Cystinosis Treatment Market is accounted for $219.36 million in 2019 and is expected to reach $321.63 million by 2027 growing at a CAGR of 4.9% during the forecast period. Various government policies to support the diagnosis and this treatment, new product developments and FDA approval are some of the factors propelling the growth of the market. However, the presences of counter fit products are hindering the growth of the market.

Cystinosis is an autosomal recessive lysosomal storage disorder characterized by the accumulation of the cysteine within the cell. It is caused by a mutation in the CTNS gene. Nephropathic cystinosis is a rare disease that usually appears in infants and children at a young age. Nephropathic cystinosis is the accumulation of cysteine in the renal system which leads to end-stage renal disease or renal failure.

Based on the application, the hospital's segment is anticipated to hold considerable market share during the forecast period due to the higher patient admissions to hospitals for treatment & renal transplantation, assistance in reimbursement for treatment, and well-structured supply chain management. By geography, North America is going to have a lucrative growth during the forecast period due to comparatively higher diagnosed patient population for nephropathic cystinosis in the region, availability of U.S. FDA approved products and research funding for new treatment approaches.

Some of the key players profiled in the Nephropathic Cystinosis Treatment Market include Recordati Rare Diseases, Mylan, Leadiant Biosciences, Inc., Horizon Therapeutics, GlaxoSmithKline plc, Eloxx Pharmaceuticals, Chiesi Farmaceutici S.p.A. and AVROBIO, Inc.

Treatment Type Covered:
• Renal Transplantation
• Therapy

Applications Covered:
• Speciality/Retail Pharmacies
• Hospitals
• Clinics
• Ambulatory Surgical Centers

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
"

"1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Nephropathic Cystinosis Treatment Market, By Treatment Type
5.1 Introduction
5.2 Renal Transplantation
5.3 Therapy
5.3.1 Systemic Depletion Therapy
5.3.2 Symptomatic Therapy
5.3.3 Cysteine Depleting Therapy

6 Global Nephropathic Cystinosis Treatment Market, By Application
6.1 Introduction
6.2 Speciality\/Retail Pharmacies
6.3 Hospitals
6.4 Clinics
6.5 Ambulatory Surgical Centers

7 Global Nephropathic Cystinosis Treatment Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa

8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiling
9.1 Recordati Rare Diseases
9.2 Mylan
9.3 Leadiant Biosciences, Inc.
9.4 Horizon Therapeutics
9.5 GlaxoSmithKline plc
9.6 Eloxx Pharmaceuticals
9.7 Chiesi Farmaceutici S.p.A.
9.8 AVROBIO, Inc.

List of Tables
Table 1 Global Nephropathic Cystinosis Treatment Market Outlook, By Region (2018-2027) ($MN)
Table 2 Global Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2027) ($MN)
Table 3 Global Nephropathic Cystinosis Treatment Market Outlook, By Renal Transplantation (2018-2027) ($MN)
Table 4 Global Nephropathic Cystinosis Treatment Market Outlook, By Therapy (2018-2027) ($MN)
Table 5 Global Nephropathic Cystinosis Treatment Market Outlook, By Systemic Depletion Therapy (2018-2027) ($MN)
Table 6 Global Nephropathic Cystinosis Treatment Market Outlook, By Symptomatic Therapy (2018-2027) ($MN)
Table 7 Global Nephropathic Cystinosis Treatment Market Outlook, By Cysteine Depleting Therapy (2018-2027) ($MN)
Table 8 Global Nephropathic Cystinosis Treatment Market Outlook, By Application (2018-2027) ($MN)
Table 9 Global Nephropathic Cystinosis Treatment Market Outlook, By Speciality\/Retail Pharmacies (2018-2027) ($MN)
Table 10 Global Nephropathic Cystinosis Treatment Market Outlook, By Hospitals (2018-2027) ($MN)
Table 11 Global Nephropathic Cystinosis Treatment Market Outlook, By Clinics (2018-2027) ($MN)
Table 12 Global Nephropathic Cystinosis Treatment Market Outlook, By Ambulatory Surgical Centers (2018-2027) ($MN)
Table 13 North America Nephropathic Cystinosis Treatment Market Outlook, By Country (2018-2027) ($MN)
Table 14 North America Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2027) ($MN)
Table 15 North America Nephropathic Cystinosis Treatment Market Outlook, By Renal Transplantation (2018-2027) ($MN)
Table 16 North America Nephropathic Cystinosis Treatment Market Outlook, By Therapy (2018-2027) ($MN)
Table 17 North America Nephropathic Cystinosis Treatment Market Outlook, By Systemic Depletion Therapy (2018-2027) ($MN)
Table 18 North America Nephropathic Cystinosis Treatment Market Outlook, By Symptomatic Therapy (2018-2027) ($MN)
Table 19 North America Nephropathic Cystinosis Treatment Market Outlook, By Cysteine Depleting Therapy (2018-2027) ($MN)
Table 20 North America Nephropathic Cystinosis Treatment Market Outlook, By Application (2018-2027) ($MN)
Table 21 North America Nephropathic Cystinosis Treatment Market Outlook, By Speciality\/Retail Pharmacies (2018-2027) ($MN)
Table 22 North America Nephropathic Cystinosis Treatment Market Outlook, By Hospitals (2018-2027) ($MN)
Table 23 North America Nephropathic Cystinosis Treatment Market Outlook, By Clinics (2018-2027) ($MN)
Table 24 North America Nephropathic Cystinosis Treatment Market Outlook, By Ambulatory Surgical Centers (2018-2027) ($MN)
Table 25 Europe Nephropathic Cystinosis Treatment Market Outlook, By Country (2018-2027) ($MN)
Table 26 Europe Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2027) ($MN)
Table 27 Europe Nephropathic Cystinosis Treatment Market Outlook, By Renal Transplantation (2018-2027) ($MN)
Table 28 Europe Nephropathic Cystinosis Treatment Market Outlook, By Therapy (2018-2027) ($MN)
Table 29 Europe Nephropathic Cystinosis Treatment Market Outlook, By Systemic Depletion Therapy (2018-2027) ($MN)
Table 30 Europe Nephropathic Cystinosis Treatment Market Outlook, By Symptomatic Therapy (2018-2027) ($MN)
Table 31 Europe Nephropathic Cystinosis Treatment Market Outlook, By Cysteine Depleting Therapy (2018-2027) ($MN)
Table 32 Europe Nephropathic Cystinosis Treatment Market Outlook, By Application (2018-2027) ($MN)
Table 33 Europe Nephropathic Cystinosis Treatment Market Outlook, By Speciality\/Retail Pharmacies (2018-2027) ($MN)
Table 34 Europe Nephropathic Cystinosis Treatment Market Outlook, By Hospitals (2018-2027) ($MN)
Table 35 Europe Nephropathic Cystinosis Treatment Market Outlook, By Clinics (2018-2027) ($MN)
Table 36 Europe Nephropathic Cystinosis Treatment Market Outlook, By Ambulatory Surgical Centers (2018-2027) ($MN)
Table 37 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Country (2018-2027) ($MN)
Table 38 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2027) ($MN)
Table 39 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Renal Transplantation (2018-2027) ($MN)
Table 40 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Therapy (2018-2027) ($MN)
Table 41 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Systemic Depletion Therapy (2018-2027) ($MN)
Table 42 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Symptomatic Therapy (2018-2027) ($MN)
Table 43 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Cysteine Depleting Therapy (2018-2027) ($MN)
Table 44 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Application (2018-2027) ($MN)
Table 45 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Speciality\/Retail Pharmacies (2018-2027) ($MN)
Table 46 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Hospitals (2018-2027) ($MN)
Table 47 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Clinics (2018-2027) ($MN)
Table 48 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Ambulatory Surgical Centers (2018-2027) ($MN)
Table 49 South America Nephropathic Cystinosis Treatment Market Outlook, By Country (2018-2027) ($MN)
Table 50 South America Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2027) ($MN)
Table 51 South America Nephropathic Cystinosis Treatment Market Outlook, By Renal Transplantation (2018-2027) ($MN)
Table 52 South America Nephropathic Cystinosis Treatment Market Outlook, By Therapy (2018-2027) ($MN)
Table 53 South America Nephropathic Cystinosis Treatment Market Outlook, By Systemic Depletion Therapy (2018-2027) ($MN)
Table 54 South America Nephropathic Cystinosis Treatment Market Outlook, By Symptomatic Therapy (2018-2027) ($MN)
Table 55 South America Nephropathic Cystinosis Treatment Market Outlook, By Cysteine Depleting Therapy (2018-2027) ($MN)
Table 56 South America Nephropathic Cystinosis Treatment Market Outlook, By Application (2018-2027) ($MN)
Table 57 South America Nephropathic Cystinosis Treatment Market Outlook, By Speciality\/Retail Pharmacies (2018-2027) ($MN)
Table 58 South America Nephropathic Cystinosis Treatment Market Outlook, By Hospitals (2018-2027) ($MN)
Table 59 South America Nephropathic Cystinosis Treatment Market Outlook, By Clinics (2018-2027) ($MN)
Table 60 South America Nephropathic Cystinosis Treatment Market Outlook, By Ambulatory Surgical Centers (2018-2027) ($MN)
Table 61 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Country (2018-2027) ($MN)
Table 62 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2027) ($MN)
Table 63 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Renal Transplantation (2018-2027) ($MN)
Table 64 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Therapy (2018-2027) ($MN)
Table 65 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Systemic Depletion Therapy (2018-2027) ($MN)
Table 66 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Symptomatic Therapy (2018-2027) ($MN)
Table 67 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Cysteine Depleting Therapy (2018-2027) ($MN)
Table 68 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Application (2018-2027) ($MN)
Table 69 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Speciality\/Retail Pharmacies (2018-2027) ($MN)
Table 70 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Hospitals (2018-2027) ($MN)
Table 71 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Clinics (2018-2027) ($MN)
Table 72 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Ambulatory Surgical Centers (2018-2027) ($MN)




"

Nephropathic Cystinosis Treatment - Global Market Outlook (2019-2027)

.